Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 915-389-0 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
ORAL - RATS (mg/kg)
TEGME: LD50: >10500, 11.3ml/kg
TetraEGME LD50: >15000 mg/kg; >2000mg/kg
Mix of tri, tetra and penta methyls: >5000mg/kg
DERMAL LD50 (mg/kg)
TEGME: Rat: Rabbit: 7.45mL/kg
Mix of tri, tetra and penta methyls: Rat LD0: >2000mg/kg, >4mL/kg
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- 19 Feb 1974 - 01 Mar 1974
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Deviations:
- no
- Principles of method if other than guideline:
- Method: BASF-Test which follows in principle the methods described in OECD Guideline 401.
5 rats per sex and dose were treated simultaneously by gavage with preparations of the test substance in water. Group-wise documentation of clinical signs was performed over the 7 day study period. The clinical signs and findings were reported in summary form. - GLP compliance:
- no
- Test type:
- standard acute method
- Limit test:
- no
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Weight at study initiation: male: 186g (mean), female 165g (mean) - Route of administration:
- oral: gavage
- Vehicle:
- water
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: 35% for 10500 mg/kg and 15% for 1050 and 2257 mg/kg - Doses:
- 1050, 2257, 10500 mg/kg bw
- No. of animals per sex per dose:
- 5 male and 5 female rats per dose
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 7 days
- Necropsy of survivors performed: yes - Statistics:
- On the basis of the observed lethality, the LD50 value was estimated or determined using a graphical evaluation of the dose response curve on probability paper.
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 10 500 mg/kg bw
- Mortality:
- no mortality occured.
- Clinical signs:
- other: Signs of toxicity comprised at 10500 mg/kg: apathy, spastic gait, dyspnea, mouth and eyelid crust formation.
- Gross pathology:
- At necroscopy no abnormalities were observed.
- Interpretation of results:
- not classified
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Executive summary:
In an acute oral toxicity study that followed the basic requirements of the OECD standard protocol guideline, male and female rats were exposed to single gavage doses of 2 -(2 -(2 -methoxyethoxy)ethoxy)ethanol at doses up to 10500mg/kg. The high dose animals showed apathy, spastic gait, dyspnea, mouth and eyelid crust formation and males also showed a sharp but transient drop in body. However, no mortality was reported implying that the LD50 is significantly in excess of the maximum dose tested.
Synopsis
LD50 (male, female) >10500mg/kg
Reference
Mean Body weights (g) MALES:
Dose group (mg/kg) |
Day 0 |
Day 3 |
Day 7 |
1050 |
190 |
210 |
205 |
2257 |
199 |
228 |
222 |
10500 |
169 |
124 |
159 |
Mean Body weights (g) FEMALES:
Dose group (mg/kg) |
Day 0 |
Day 3 |
Day 7 |
1050 |
165 |
184 |
167 |
2257 |
163 |
178 |
170 |
10500 |
168 |
192 |
178 |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 10 500 mg/kg bw
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- 1960-62
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
- Remarks:
- Acceptable, study containing basic data which suggests that basic scientific principles have been met. This is sufficient to judge the results reliable as a contribution to the understanding of the toxicity of this substance.
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- Study pre-dates guidelines. Similar to one day cuff method of Draize (J Pharmac Exp Therap, 82, 377, 1944)
- GLP compliance:
- no
- Test type:
- standard acute method
- Limit test:
- no
- Species:
- rabbit
- Strain:
- New Zealand White
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Weight at study initiation: ~2.5kg
- Age at study initiation: 3-5 months.
- Other: albino rabbits used.
- Diet: Rockland rabbit diet - Type of coverage:
- occlusive
- Vehicle:
- unchanged (no vehicle)
- Details on dermal exposure:
- TEST SITE
- Area of exposure: Fur removed from entire trunk area by clipping
- % coverage:
- Type of wrap if used: impervious plastic film (VINYLITE)
OTHER
- Animals immobilised during 24 hour exposure period. - Duration of exposure:
- 24 hours
- Doses:
- 2.5, 5.0, 10, 20ml/kg
- No. of animals per sex per dose:
- 2, 4, 2, 1 respectively.
- Control animals:
- other: no but a large number of other substances also tested which acted as reference materials.
- Details on study design:
- - Duration of observation period following administration: 14 days after wrap removed following 24 hour exposure.
- Statistics:
- The moving average method was used to calculate the LD50
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 7.1 mL/kg bw
- Mortality:
- All animals in top two dose groups died but none in lower two dose groups.
- Clinical signs:
- other: Marked erythema seen. Otherwise no signs in lower two dose groups.
- Gross pathology:
- Hihg dose animal and one of the 10ml/kg animals showed internal and lung hemorrhage. Livers were congested and kidneys pale and possibly swollen.
- Interpretation of results:
- not classified
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Executive summary:
In an acute dermal toxicity in rabbits in which key basic details were reported, an LD50 of 7.1ml/kg was obtain. Exposure was under occluded conditions.
Synopsis
LD50=7.1ml/kg
Reference
Results:
Dose (ml/kg) |
Mortality |
Day of death |
Average weight gain (g) |
10 |
2/2 |
Both day 4 |
|
5 |
0/4 |
- |
135 (SD=163) |
2.5 |
0/2 |
- |
100 (SD=130) |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
Additional information
A number of LD50 studies are available in rats using the substances methyl triglycol and methyl tetraglycol, two main components of this UVCB/multicomponent substance, and mixtures containing significant amounts of these substances. All consistently show that the LD50 is very high. The key study selected is considered representative of the UVCB/multicomponent substance and shows that an LD50 was not identified at the maximum tested dose of 10500mg/kg. This conclusion is supported by the read across justification document attached to chapter 13 of the lead registrant's dossier. In a poisoning case, a young child self administered a huge dose estimated in excess of 25g/kg of a formulated brake fluid based on triethylene glycol ethers. Whilst intensive medical support was briefly required, the patient made a full recovery.
Acute dermal toxicity data is available in both the rat and rabbit for tri and tetraethylene glycol methyl ether and formulations containing these substances. An LD50 of ~7.5mL/kg was established in the rabbit whilst a figure of >2000mg/kg was established in the rat from a recent GLP limit study using a mixture of primarily tri, tetra and penta ethylene glycol methyl ethers. In a sub-chronic dermal toxicity study using rats (reported in chapter 7.5.2) a NOAEL of 4000mg/kg was established, indicating that the acute LD50 must be significantly in excess of this. Based on the low dermal absorption rate of the substance, (see chapter 7.1.2), acute toxicity by the dermal route would not be expected. This conclusion is supported by the read across justification document attached to chapter 13 of the lead registrant's dossier.
There is no acute studies by inhalation available for this UVCB/multicomponent substance. Taking into account the very low volatility and uses of this substance, along with the acute data from other routes, it can be concluded that there is no hazard from the inhalation of saturated vapour concentrations at ambient temperatures.
Based on observations from the lower members, higher molecular weight species in this homologous series of polyalkylene glycol methyl ethers will show decreasing potential for acute toxicity so these results can be considered representative of this UVCB/multicomponent substance.
Justification for classification or non-classification
Base on the available data, the substance clearly does not meet the criteria for classification for acute toxicity by any route of exposure.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.